focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adamas Named Best Asia Pacific Lender

2 Mar 2015 07:00

RNS Number : 1741G
Adamas Finance Asia Limited
02 March 2015
 



 

ADAMAS FINANCE ASIA LIMITED

 

ADAMAS NAMED BEST ASIA PACIFIC LENDER

 

 

Adamas Finance Asia Ltd ("ADAM" or "the Company") announces that its Hong Kong-based investment manager, Adamas Asset Management ("Adamas") has beaten major international competition to be named Best Asia Pacific Lender in the prestigious Private Debt Investor Annual Awards for 2014.

 

Adamas, which has US$620 million under management, saw off close challenges from investment giants, KKR Asset Management and Piramal Fund Management to secure the award.

 

Over the past five years, Adamas has generated consistent gross internal rates of return typically averaging around 30% by providing structured loans to well-managed Chinese SMEs.

The firm mitigates the risks of fraud, corruption, weak contractual enforcement and legal ambiguity sometimes associated with Chinese investment by conducting stringent due diligence, securing a hold over recoverable collateral, and applying detailed attention to loan documentation and preparation for possible legal enforcement.

Since 2010, the Adamas team has experience in providing short-term credit funding to 54 SMEs within China, successfully exiting from 42, and experiencing only five delays in repayments of principal or interest. In each of the five cases, it commenced proceedings in the Chinese courts, with the result that all five defaulters subsequently settled in full either ahead of court action or as a result of judicial decisions.

 

ADAM's exposure to the investment opportunities identified by Adamas has to date been limited by lack of investment funding yet to be realised from its planned programme of disposals. On 18 December 2014 ADAM announced its first major disposal from its legacy portfolio, agreeing the redemption of its interest in the Chinese pharmaceutical company, Global Pharm Holdings Group Inc, for US$25 million and crystallising a US$2.6 million profit over book value.

 

ADAM Chairman, John Croft said: "At a time when there have been well documented issues with certain Chinese companies quoted in London and on other markets, the achievement by Adamas in beating the likes of KKR to be named Best Asia Pacific Lender demonstrates how it is possible with a carefully structured approach to generate attractive and consistent returns from quality Chinese credit-funding deals."

 

He added: "Following the agreement for the redemption of our first legacy investment in December we are now looking forward to participating more actively in projects identified by the Adamas teams, and generating returns for shareholders."

 

 

 

Enquiries:

 

Adamas Finance Asia Limited

John Croft

+44 (0) 1825 830587

Nominated Adviser and Joint Broker

W H Ireland Limited

Tim Feather/Liam Gribben

+44 (0) 113 394 6600

Joint Broker

NSBO

Laurie Pinto

+44 (0) 20 7024 4600

Public Relations Advisers

First City Public Relations (Hong Kong)

Allan Piper

+852 2854 2666

Tavistock Communications (London)

Simon Hudson

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADGGDXDGGBGUB
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.